The myDNA Psychotropic Pharmacogenomic (PGx) test can help your clinician understand how your DNA might impact your response to specific mental health medications.
May help reduce the risk of experiencing medication side effects.
By assessing certain genetic markers, your risk of possible side effects can be predicted, even prior to starting the medication. This can help your clinician personalize dosage and choice of medication.
May reduce some of the guesswork around medication selection.
PGx testing may help to reduce some of the “trial and error,” which can be involved in prescribing medications. The myDNA test provides your clinician with information that can further assist them in prescribing you an effective medication sooner, potentially saving you time and money.
Results last a lifetime.
The test results presented in the report will assist your clinician, now and in the future, to decide if one of the covered medications is right for you.